{"nct_id":"NCT04526509","title":"Master Protocol to Assess Safety and Dose of First Time in Human Next Generation Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Advanced Solid Tumors","status":"TERMINATED","status_verified_date":"2024-11","start_date":"2020-12-21","start_date_type":"ACTUAL","primary_completion_date":"2023-06-08","primary_completion_date_type":"ACTUAL","completion_date":"2023-06-08","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["ADAP"]}